A Randomized, Double-Blind, Vehicle Controlled, Parallel Group Study of the Dose-Response Profile of A-101 Topical Solution in Subjects With Seborrheic Keratosis.
Phase of Trial: Phase II
Latest Information Update: 07 Jan 2019
Price : $35 *
At a glance
- Drugs Hydrogen peroxide (Primary)
- Indications Seborrhoeic keratosis
- Focus Therapeutic Use
- Sponsors Aclaris Therapeutics
- 12 Nov 2018 Status changed from active, no longer recruiting to completed.
- 07 Oct 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Jun 2014 New trial record
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History